tirzepatide weight loss vs ozempic In adults with obesity but not diabetes, leads to significantly greater than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Semaglutide vs. Tirzepatide - Global

Our patients lead busy lives and are coping with the stress and anxiety this brings and the impact on their general health and well-being

What You Can Do Next Log your food for 35 days Add or reintroduce resistance training Set a protein intake target: ~1.6g per kg of body weight per day Cut back on ultra-processed snacks and calorie-rich drinks Prioritise sleep and stress management Focus on consistency, not perfection Final Thoughts GLP-1 medications are powerful tools, but they are not magic fixes

Wegovy is approved for weight loss and heart disease treatment in adults who are obese or overweight with known heart conditions

Whole food sources of fiber should remain the foundation wherever possible, with supplements serving as a practical way to help fill gaps when intake is lower

Players are leveraging investments and expansion opportunities to capitalize on the rising demand for diabetes and obesity treatment

The company's products have passed international testing organizations: German TUV company, French BV company, and Europe CE certification